Domestic mutual reliance is a seamless partnership that enables the FDA and states with comparable regulatory public health systems, as trusted partners, to rely on, coordinate with, and leverage one another’s work, data, and actions to meet the public health goal of a safe national food supply.
The FDA works with our state partners to build and recognize high quality programs using nationally recognized regulatory program standards like Manufactured Food Regulatory Program Standards (MFRPS) and the Animal Feed Regulatory Program Standards (AFRPS). Such collaboration provides opportunities for the FDA and state partners to lay a quality foundation for sharing information and working together on regulatory services and food protection that industry and consumers can trust.
Partnership agreements formally document our domestic mutual reliance relationships to improve foodborne illness prevention, detection, and response in an Integrated Food Safety System (IFSS). Partners collaborate in the following operational areas to build a highly trained workforce, coordinate food safety inspection efforts, share data, leverage organizational resources, focus on prevention, and better respond to outbreaks.
- Information Sharing and Public Health Protection through Legal Authority
- Domestic Mutual Reliance Planning and Evaluation
- Leveraging of Resources
- Information Technology
- Risk-Based Inspection Program
- Compliance and Enforcement
- Industry and Community Relations
- Laboratory Support
- Emergency Response
- August 2023 – The FDA created an infographic showing the accomplishments from 2017-present of the domestic mutual reliance partnership agreement with the Alaska Department of Environmental Conservation.
- July 2023 - The FDA worked closely with state regulatory partners in Florida, Iowa, Pennsylvania, Utah, Virginia, and Wisconsin to achieve the major milestone of accepting 1,000 non-contract inspections. Also known as NCIs, these non-high-risk inspections are conducted by the state under its own authority in which no other regulatory action was required. Similarly, these states have been able to leverage a similar number of FDA inspections to support their oversight activities. NCIs greatly increase efficiency and minimize duplication of efforts for both regulators and industry. These efficiencies enable the FDA and our state regulatory partners to maximize the impact of millions of dollars in state and federal funding, thereby avoiding additional burden to the American taxpayer and enabling regulators to expand coverage and focus limited resources on areas of highest risk to advance food safety for consumers. Learn more about NCIs in this Partnership for Food Protection story.
- June 2023 - Overview of the Recall Integration Partnership Project
- May 2023 – The FDA announced the signing of a developmental partnership agreement with the Puerto Rico Department of Consumer Affairs (DACO). The agreement will focus on emergency response, partner training, and minimizing duplicative efforts.
- March 2023 – The latest Partnership for Food Protection newsletter featured two employees from the FDA’s Office of Regulatory Affairs: Division Director Tim Mueller and Consumer Safety Officer Priscilla Neves. Mueller discussed the ORA Data Exchange and its connection to domestic mutual reliance and an integrated food safety system. Neves discussed how her current role overseeing the domestic mutual reliance project in ORA enables her to collaborate with partners to advance food safety.
- February 2023 – The FDA signed a domestic mutual reliance partnership agreement with the New York Department of Agriculture and Markets. New York takes an innovative approach to collaborate on food safety for domestically produced foods, imported foods, and laboratory testing in conjunction with the FDA. This ORA News and Stories article details the agreement.
- February 2023 – In this Partnership for Food Protection story, ORA Human and Animal Food State Liaison Julie Vosilus and Chief of the Food and Consumer Safety Bureau Mark Speltz in the Iowa Department of Inspections and Appeals discuss domestic mutual reliance in Iowa, which recently signed a partnership agreement with the FDA.
- December 2022 – The FDA announced the signing of three new domestic mutual reliance partnership agreements with the Minnesota Department of Agriculture, Virginia Department of Agriculture and Consumer Services, and Iowa Department of Inspections and Appeals. The agreements will focus on inventory reconciliation, training, and work planning, among other areas. Associate Commissioner for Regulatory Affairs Judy McMeekin discusses the agreements in Food Safety Magazine.
- October 2022 – The Coordinated Outbreak Response & Evaluation (CORE) Network coordinates FDA responses during outbreak investigations. How does CORE use the incident command system with local, state, and federal partners? Learn more about domestic mutual reliance in action through the Food Safety Magazine article, "The Incident Command System and Foodborne Illness Outbreak Investigations."
- October 2022 – The FDA released a TechTalk podcast entitled “Data Exchange in the New Era of Smarter Food Safety” to discuss the platform created by the FDA’s Office of Regulatory Affairs to securely share information between the agency and regulatory partners at the state and local levels. This platform supports domestic mutual reliance and other key initiatives to ensure a safe food supply across the country.
- September 2022 – The FDA learned that an imported honey product promoted and sold for sexual enhancement had been seized by the Fresno County Sheriff’s Office for presumptive methamphetamine. Though confirmatory results were negative for methamphetamine, a search revealed that the FDA had previously issued an import alert for the product for containing sildenafil, the active ingredient in Viagra®. Because the shipping paperwork suggested the product was being sold to a grocery store in New York, the FDA alerted the NY State Department of Agriculture and Markets (NYSAGM). NYSAGM responded and 144 sachets of this product were seized and destroyed under signed waiver during the investigation.
- July 2022 – The West Virginia Department of Agriculture analyzed tahini samples from grocery stores, which were collected by the state’s health department as part of a joint Rapid Response Team preparedness exercise. Laboratory analysis found the samples to contain Salmonella. Notification was provided to the West Virginia Department of Health and Human Resources, which referred this to its counterpart in New Jersey, where the product’s importer and distributor was located. In coordination with West Virginia and the FDA, the New Jersey Department of Health (NJDOH) reached out to the firm. At the urging of NJDOH, the firm chose to conduct a voluntary recall. As a result, the NJDOH did not pursue any additional enforcement actions, i.e., embargo of their products and inspection/investigation of multiple locations.
- August 2022 – The FDA Winchester Engineering Analytical Center (WEAC) participated in an exercise sponsored by Rhode Island Emergency Management Agency (RIEMA), per a partnership agreement between the two, to evaluate the readiness and capability to respond to a nuclear incident. RIEMA collected and delivered samples to WEAC, and WEAC performed gamma-ray analysis and reported data to REIMA. All participants achieved the exercise objectives, and WEAC delivered analytical results within two hours of getting the samples.
- August 2022 – The FDA created an infographic explaining our partnership with the Alaska Department of Environmental Conservation.
- July 2022 – The FDA produced a video providing an overview of domestic mutual reliance and how we work with states to advance food safety.
- The FDA, CDC, and state and local partners worked together to investigate a multistate outbreak of Listeria infections linked to Dole packaged leafy greens that sickened 18 people in 13 states. The FDA analyzed positive samples collected by Dole from harvesting and processing equipment. Results showed that the Listeria strain from the equipment matched both the strain causing the illnesses and the strain from product samples collected by the Michigan Department of Agriculture and Rural Development during the December 2021 outbreak investigation, and a routine sample collected by the Georgia Department of Agriculture prior to the investigation. Dole issued two voluntary recalls, stopped using the equipment, and temporarily halted production at two processing facilities. As of April 4, 2022, the CDC has declared the outbreak over.
- June 2022 – The Maryland State Department of Health Laboratories Administration analyzed samples of freeze-dried blueberries collected from grocery stores. Lab analysis found that one product contained a high amount of lead (for which there is no established action or regulatory level in this food). The FDA determined that the blueberries represented a hazard to consumers and referred the sample to the California Department of Public Health (CDPH), where the product’s distributor was located. CDPH followed up with the firm, which voluntarily recalled the product and implemented additional quality assurance processes regarding heavy metals.
- April 2022 – A joint inspection by the FDA and the New York State Department of Agriculture and Markets resulted in the seizure and destruction of nearly 5,000 pounds of rodent-defiled food. The filth conditions had been discovered during a routine FDA inspection of a firm in Brooklyn. The FDA coordinated with the state to leverage individual authorities. Thanks to this collaboration, food deemed unfit for human consumption was prevented from distribution to consumers.
- March 2022 – The state of Connecticut and the FDA worked closely together regarding an asparagus sample imported from Peru that was found to contain carbofuran, a potentially harmful pesticide that is not allowed at any level in asparagus. The Connecticut Division of Consumer Protection and the Connecticut Agricultural Experiment Station collected and tested the asparagus. The FDA used the state’s test results and traceback information to add the foreign processor to the FDA’s Import Alert 99-05, which subjects the firm to detention without physical examination. This sample was collected as part of the Laboratory Flexible Funding Model (LFFM) Cooperative Agreement Program.
- March 2022 – The FDA announced the signing of a domestic mutual reliance partnership agreement with the Minnesota Department of Agriculture – the first such agreement to include both human and animal food. The work will focus on data and information sharing, official establishment inventory reconciliation and maintenance, and establishing key metrics.
- February 2022 – Strong federal-state collaboration facilitated the voluntary recall of product from Royal Ice Cream. The company initiated the recall after FDA sampling revealed the presence of Listeria monocytogenes on processing equipment, and it expanded the recall after the Massachusetts Department of Public Health detected the bacteria in retail samples. Royal Ice Cream is working with the FDA to investigate the cause.
- February 2022 – In this Food Safety Magazine “Food Safety Matters” podcast, FDA Assistant Commissioner for Partnerships and Policy Erik Mettler and Assistant Commissioner for Human and Animal Food Operations Michael Rogers joined Travis Waller of the Utah Department of Agriculture and Food to discuss a “day in the life” of a domestic mutual reliance partnership agreement with the FDA.
- November 2021 – The FDA and the Florida Department of Agriculture and Consumer Services (FDACS) recently reached a major milestone of exchanging and accepting more than 500 of each other’s manufactured food inspection reports. The FDA’s enhanced IT support has greatly increased the efficiency of data sharing between the agency and state partners. These efforts capture the intent of the domestic mutual reliance partnership agreement between FDACS and the FDA, signed on October 29, 2021, to share program information that will improve public health by minimizing duplication of work and leveraging resources. For more examples of the benefits of domestic mutual reliance, visit DMR Benefits for Industry and Consumers.
- On October 7, 2021, the FDA announced the signing of four domestic mutual reliance partnership agreements with the California Department of Public Health, Florida Department of Agriculture and Consumer Services, Utah Department of Agriculture and Food, and Wisconsin Department of Agriculture, Trade and Consumer Protection Division of Food and Recreational Safety.
- October 2021 – Food Safety Magazine discusses the FDA’s new domestic mutual reliance partnership agreements with California, Florida, Utah, and Wisconsin. FDA Assistant Commissioner for Partnerships and Policy Erik Mettler is the author.
- July 2021 - Our new video highlights how the FDA’s Rapid Response Team program embodies domestic mutual reliance in action during human and animal food emergencies. The video features a case study involving the federal-state teams from Maryland and Wisconsin, posters from the annual meeting, and much more.
- May 2021 - Thanks to effective federal-state communication channels, Giant Eagle, Inc., Hy-Vee, Inc., and the Kroger Co. were able to work with the FDA to quickly issue a voluntary recall of Chicken Street Taco Kits supplied by Reser’s Fine Foods, due to the possibility the product may contain an undeclared egg allergen.
- April 2021 - Food Safety Magazine describes how domestic mutual reliance builds upon the successes of FDA’s Rapid Response Teams model in collaboration with states to improve food safety in the United States. Erik Mettler, FDA Assistant Commissioner for Partnerships and Policy, and Natalie Adan, Food Safety Division Director of the Georgia Department of Agriculture, are co-authors.
- Video: Domestic Mutual Reliance Overview
- Food Safety Modernization Act
- 20.88 Agreements Database
- Commissioning Information
- Office of Human and Animal Food Operations (OHAFO) Boundary Map
- Partnership Agreements
Do you have questions or would you like more information? Please submit them to OP.Feedback@fda.hhs.gov.